Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mudavath, Ravi Naik"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vasudevan Sajini, Deepak, Thaggikuppe Krishnamurthy, Praveen, Chakkittukandiyil, Amritha, Mudavath, Ravi Naik
Publikováno v:
Neurochemical Research; Jun2024, Vol. 49 Issue 6, p1577-1587, 11p
Autor:
Vasudevan Sajini, Deepak, Thaggikuppe Krishnamurthy, Praveen, Chakkittukandiyil, Amritha, Mudavath, Ravi Naik
Publikováno v:
Neurochemical Research; Jun2024, Vol. 49 Issue 6, p1588-1591, 4p
Repurposing of FDA Approved Drugs and Neuropep peptides as Anticancer Agents Against ErbB1 and ErbB2
Autor:
Sunil Kumar Patnaik, Akey Krishna Swaroop, Mudavath Ravi Naik, Jubie Selvaraj, Moola Joghee Nanjan Chandrasekar
Publikováno v:
Drug Research.
ErbB1 and ErbB2 are the most important biological targets in cancer drug discovery and development of dual inhibitors for the cancer therapy. FDA approved drugs and Neuropep peptides were used to fit into the ATP binding site of the tyrosine kinases;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2058b6400e766f57b5d3799fa3399ba1
https://doi.org/10.1055/a-2030-4078
https://doi.org/10.1055/a-2030-4078
Autor:
Esakkimuthukumar M., Akey Krishna Swaroop, Sunil Kumar Patnaik, Rajesh Kumar R., Praveen T. K., Mudavath Ravi Naik, Jubie S.
Publikováno v:
RSC Advances. 12:31293-31302
2,3,5-Tri substituted pyrazole analogues are identified as HIF-1α mimetics, which block the VHL interaction for diabetic wound healing therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad4a0bb785f4de272aabd338bd005ea0
https://doi.org/10.1039/d2ra05364k
https://doi.org/10.1039/d2ra05364k